# Use of Ziv Aflibercept in Different Retinal Diseases

> **NCT04290195** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amin El Sayed Nawar** · enrollment: 55 (actual)

## Conditions studied

- Central Retinal Vein Occlusion With Macular Edema

## Interventions

- **DRUG:** Ziv-Aflibercept 25 MG/ML [Zaltrap]

## Key facts

- **NCT ID:** NCT04290195
- **Lead sponsor:** Amin El Sayed Nawar
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290195, "Use of Ziv Aflibercept in Different Retinal Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04290195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*